Enable JavaScript to visit this website.
Skip to main content

User menu

  • Log in
  • Register

Main menu

  • Pfizer Products
  • Therapy Areas

Search form

Pfizer Home
  • ZINFORO®

Clinical Information

  • Community-acquired pneumonia (CAP)
  • Complicated skin and soft tissue infections (cSSTI)
    • Unmet Needs in cSSTI
    • Zinforo®: Mode of Action (MOA)
    • The ZINFORO® Patient
    • Clinical Efficacy
    • cSSTI pivotal clinical studies
    • Zinforo® Microbiology in cSSTI
    • Zinforo® for the Treatment of cSSTI
    • Safety Information
    • Dosing Information

Support & Services

  • Clinical Update (6)
  • Videos and Webinars
  • Zinforo® Summary of Prescribing Information
Other indications

Clinical Information List

Unmet Needs in cSSTI

Zinforo®: Mode of Action (MOA)

The ZINFORO® Patient

Clinical Efficacy

cSSTI pivotal clinical studies

Zinforo® Microbiology in cSSTI

Zinforo® for the Treatment of cSSTI

Safety Information

Dosing Information

Pfizer Home
  • ZINFORO®

Clinical Information

  • Community-acquired pneumonia (CAP)
  • Complicated skin and soft tissue infections (cSSTI)
    • Unmet Needs in cSSTI
    • Zinforo®: Mode of Action (MOA)
    • The ZINFORO® Patient
    • Clinical Efficacy
    • cSSTI pivotal clinical studies
    • Zinforo® Microbiology in cSSTI
    • Zinforo® for the Treatment of cSSTI
    • Safety Information
    • Dosing Information

Support & Services

  • Clinical Update (6)
  • Videos and Webinars
  • Zinforo® Summary of Prescribing Information
Find out more
Find out more
Find out more

Footer menu

  • Pfizer.com
  • Privacy Policy
  • Terms of Use
  • Send us a Medical Question
  • Request for a Publications Update

Copyright footer block

Copyright © 2021 Pfizer Limited, India. All rights reserved. Applicable for Pfizer Products, Product Microsites and Therapy Areas section of the website:
•All content published herein is intended and strictly only for informational, educational, academic and/or research purposes and shall not be utilized to diagnose or treat a health problem or disease without referring to the full prescribing information for list of approved indications as contained in the product package insert
•While due care and caution has been taken to ensure that the content herein is free from mistakes or omissions, Pfizer makes no claims, promises or guarantees about the accuracy, completeness or adequacy of the information herein

These pages are not intended for patients or for members of the general public. The web pages contain promotional content. For the use only of Registered Medical Practitioners or a Hospital or a Laboratory. Full prescribing information available on request. For more details on, Who is a Registered Medical Practitioner, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April2021.
Address: The Capital,  A Wing, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra Kurla Complex, Bandra East, Mumbai – 400051, India.

For the use only of Registered Medical Practitioners* or a Hospital or a Laboratory.

These pages are not intended for patients or for members of the general public. The web pages contain promotional content.

If you select ‘No’, you will be redirected to Pfizerindia.com.

For more details on, Who is a Registered Medical Practitioner, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.

Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, ‘G’ Block, Bandra Kurla Complex, Bandra East, Mumbai – 400051.
PP-UPA-IND-0089. 11/2/2021.

YesNo